Produktbeschreibung
Ipidacrine is a reversible cholinesterase inhibitor that enhances cholinergic transmission by blocking acetylcholinesterase and butyrylcholinesterase activity. In experimental models, administration at a dose of 6.7 mg/kg produced a significant increase in the intracavernous pressure-to-mean arterial pressure ratio following nerve electrostimulation, demonstrating noninferiority to a standard phosphodiesterase type 5 inhibitor. This compound is primarily utilized in research settings to investigate erectile dysfunction mechanisms, particularly in cases with reduced responsiveness to conventional cyclic nucleotide-based approaches.
* MwSt. und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
